Dividend stocks are attractive for their steady income, stability, and growth potential, especially amid low interest rates ...

AbbVie (ABBV) shares dip for 7th day, but analysts see buying opportunity after recent setback in schizophrenia drug trials.

Which healthcare stock can dividend investors safely buy? Let's consider two excellent options: AbbVie (NYSE: ABBV) and Amgen ...

As most advisors are well aware, high stock prices have pushed down the market’s dividend yield. Barron’s ran a screen for ...

One of the best ways to build wealth is with dividend stocks – especially if they’re attached to solid companies with a ...

These 5 High-Yield Dividend Stocks Could Turn It Into More Than $300 of Annual Passive Income. Billionaire Ken Griffin of ...

Here's a comparison of top dividend ETFs by performance, yield and strategy to help you decide which is the better buy for ...

The added benefit is that AbbVie is a "Dividend King," which means it has consistently paid and increased dividends for the ...

Discover how AbbVie investors that bought the anxiety over the loss of Humira exclusivity are sitting on massive gains. Read ...

Cerevel wasn't a one-trick pony, however. For its considerable spend, AbbVie also acquired several other pipeline programs from the neuroscience-focused biotech. The most promising of these is ...

AbbVie reports disappointing mid-stage data for its schizophrenia drug. Jason Snipe of Odyssey Capital still likes AbbVie ...

Strategists at Wells Fargo Investment Institute see the fed funds rate dropping a total of one percentage point this year and ...